von Willebrand disease
VWD
Von Willebrand disease (VWD) is the most common inherited bleeding disorder, caused by a deficiency or dysfunction of von Willebrand factor (VWF), a protein that helps blood clot. It affects both men and women and can lead to symptoms like easy bruising, frequent nosebleeds, heavy menstrual bleeding, and prolonged bleeding after injury or surgery.
There are three main types: Type 1 (mild, partial deficiency), Type 2 (moderate, abnormal function), and Type 3 (severe, almost no VWF). Diagnosis involves blood tests that measure VWF levels and function.
Treatment depends on the type and severity and may include desmopressin (to release stored VWF), VWF replacement therapy, or antifibrinolytics. Most people with VWD can manage the condition with proper medical care and precautions.
AI Summary of Treatment Experiences
Not medical advice.
Based on the submitted reviews, the treatment landscape for von Willebrand disease includes desmopressin as first-line therapy for type 1 VWD and some type 2 cases, with IV administration being the most reliable route. Tranexamic acid is noted as a useful first-line treatment for bleeding episodes, particularly mucosal bleeding, offering an inexpensive and well-tolerated alternative that works by stabilizing clots before considering factor replacement therapy. Other treatment options mentioned include aminocaproic acid and recombinant VWF, though specific details about these treatments were not provided in the reviews.
Treatments Shared by the Community
Explore what patients, caregivers, and clinicians have said about these treatments.
4 Treatments for von Willebrand disease
Lysteda
DDAVP
Vonvendi
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.